Company intelligence / Profile preview

Veniti

Fremont, California, United Statesveniti.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

Veniti developed and commercialized the Vici Venous Stent System for treating venous obstructive disease. The Vici stent received CE Mark in 2013 and was supported by pivotal clinical data from the VIRTUS study. At acquisition, a PMA application was under FDA review.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Boston Scientific (investor and global distributor)

Beyond the preview

Go deeper on Veniti.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veniti.

Explore the full profile